POSTER SESSION IV
Tuesday, March 20, 2012   —  1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GYNECOLOGIC PATHOLOGY & OBSTETRICS



Poster#Title and AuthorsItinerary
Planner
118 Immature Metaplastic CIN1: A Variant with Intense P16 Staining and Low Proliferative Index (1226)
C Parra-Herran, B Lane, MS Hirsch, MR Nucci, CP Crum, M Herfs - Brigham and Women´s Hospital, Boston, MA 		Add
119 Stathmin, a Microtubule Destabilizing Protein, Is Overexpressed in Most High, but Not Low Grade, Cervical Squamous Intraepithelial Lesions (1160)
BE Howitt, MR Nucci, R Drapkin, CP Crum, MS Hirsch - Brigham & Women´s Hospital, Boston, MA 		Add
120 Expression of Stem Cell Marker ALDH1 in Cervical Intraepithelial Neoplasia (1143)
P Gong, J Palazzo - Thomas Jefferson University Hospital, Philadelphia, PA 		Add
121 The Stem Cell Associated Transcription Factor Sox2 as a Diagnostic Marker of Cervical Neoplasia (1148)
K Gwin, R Buell-Gutbrod, N Lee, E Lengyel, A Montag, MK Mirza - University of Chicago, Chicago, IL 		Add
122 P16/MIB-1 Immunoreactivity and HPV DNA Status in Tubal Metaplasia of Endocervical Epithelium: Is There Any Correlation? (1141)
JC Gomez-Gelvez, Z Zhang, M Raoufi, TE Buekers - Henry Ford Hospital, Detroit, MI 		Add
123 PAX8 Immunohistochemical (IHC) Expression in Endocervical Glandular Lesions (1111)
R Danialan, M Assaad, RW Cartun, S Mandavilli - Hartford Hospital/Clinical Laboratory Partners, Hartford, CT 		Add
124 The Desmoplastic Stromal Response as Defined by Positive a-Smooth Muscle Actin Staining Is Predictive of Invasion in Adenocarcinoma of the Uterine Cervix (1168)
SM Jordan, T Watanabe, K Osann, BJ Monk, F Lin, JK Rutgers - University of California, Irvine, Orange, CA; University of California, Irvine, Irvine, CA; Creighton University School of Medicine, Phoenix, AZ; Long Beach Memorial Medical Center, Long Beach, CA 		Add
125 Early Invasive Cervical Adenocarcinoma: Is Radical Treatment Indicated? (1102)
K Ceballos, K Onuma, J Hauspy, P Rubabaza, A Rajagopalan, D Shaw, D Daya - University of British Columbia, Vancouver, BC, Canada; St. Augustinus Hospital, Antwerp, Belgium; McMaster University, Hamilton, ON, Canada; Halton Health Care Services, Oakville-Trafalgar Site, Oakville, ON, Canada 		Add
126 Mesonephric-Like Endometrioid Glandular Proliferations: A Morphologically Distinct Form of Metaplasia (1223)
LY Pan, FN Moore, TA Longacre - Stanford University, Stanford, CA 		Add
127 Papillary Proliferation of the Endometrium: A Clinicopathologic Study of 56 Cases (1163)
PP Ip, JA Irving, GW McCluggage, RH Young - University of Hong Kong, Queen Mary Hospital, Hksar, Hong Kong; Royal Jubilee Hospital, Victoria, BC, Canada; Belfast Health and Social Care Trust, Belfast, United Kingdom; Massachusetts General Hospital, Boston, MA 		Add
128 K-ras Mutations in Mucinous Lesions of Uterus (1155)
M He, CL Jackson, V Breese, MM Steinhoff, J Xiong, WD Lawrence - Brown University/Women Infants Hospital, Providence, RI; Brown University/Rhode Island Hospital, Providence, RI 		Add
129 Endometrial Biopsy Interpretation Using WHO 2004 and EIN Criteria: An Analysis of 77 Cases with Emphasis on Conservative Management (1158)
KK Hooper, PJ Stone, CM Quick - UAMS, Little Rock, AR 		Add
130 Secretory Endometrial Intraepithelial Neoplasia (SEIN) Arising in Secretory Endometrium: Histologic & Immunohistochemical Features of a Rare EIN Variant (1261)
W Winham, K Hooper, P Stone, C Quick - UAMS, Little Rock, AR 		Add
131 PTEN Status and Frequency of Endometrioid Carcinoma and Its Precursors Arising in Functional Secretory Endometrium: An Immunohistochemical Study of 29 Cases (1248)
RA Simon, K Hansen, J Xiong, CJ Sung, WD Lawrence, MR Quddus - Brown University/Women & Infants Hospital, Providence, RI 		Add
132 Endometrial Intraepithelial Neoplasia Involving Polyps: A Followup Study (1233)
CM Quick, GL Mutter, AR Laury, CP Crum, MR Nucci - UAMS, Little Rock, AR; Brigham and Women´s Hospital, Boston, MA; UCLA, Los Angeles, CA 		Add
133 Correlation of CXCL12/CXCR4 Expression and FOXP3 Cell Infiltration in Normal Endometrium, Typical and Atypical Hyperplasia and Endometrioid Adenocarcinoma (1201)
N Maroo, RE Dina - Hammersmith Hospital, Imperial College London, London, United Kingdom 		Add
134 Does Hormonal Therapy Affect the Morphology of Uterine Smooth Muscle Tumors? (1253)
BM Turner, FA Tavassoli - Yale School of Medicine, New Haven, CT 		Add
135 Gene Expression Signatures Differentiate Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma (1112)
B Davidson, V Abeler, E Hellesylt, A Holth, I-M Shih, GB Kristensen, T Skeie-Jensen, Y Yang, T-L Wang - Norwegian Radium Hospital, Oslo, Norway; Johns Hopkins Medical Institutions, Baltimore, MD; National Institutes of Health, Bethesda, MD 		Add
136 Do Deeper Sections Increase the Yield of Detection of Serous Tubal Intraepithelial Carcinoma (STIC) in the ´Sectioning and Extensively Examining the Fimbriated End´ (SEEFIM) Protocol? (1194)
E Mahe, S Tang, P Deb, A Lytwyn, M Sur, D Daya - McMaster University, Hamilton, ON, Canada 		Add
137 Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma (1255)
R Vang, K Visvanathan, A Gross, E Maambo, M Gupta, E Kuhn, R Li, BM Ronnett, JD Seidman, A Yemelyanova, I-M Shih, PA Shaw, RA Soslow, RJ Kurman - The Johns Hopkins Hospital, Baltimore; The Johns Hopkins Bloomberg School of Public Health, Baltimore; Washington Hospital Center, Washington, DC; University of Toronto, University Health Network, Toronto, Canada; Memorial Sloan- Kettering Cancer Center, New York 		Add
138 Genetic Instability in Serous Tubal Intraepithelial Carcinoma and Tubo-Ovarian Dysplasia from Prophylactic Oophorectomies for Genetic Risk (1229)
F Penault-Llorca, A Tchirkov, I Raoelfils, A Cayre, E Pierre, P Vago, G Chene - Centre Jean Perrin, Clermont-Ferrand, France; CHU, Clermont-Ferrand, France 		Add
139 Occult Gynecological Cancer in Prophylactic Risk-Reducing Salpingo-Oophorectomies from BRCA Mutation Carriers (1259)
AE Walts, J Gross, I Cass - Cedars-Sinai Medical Center, Los Angeles 		Add
140 Characteristic Features of Serous Tubal Intraepithelial Carcinoma and Its Co-Existing Invasive Carcinomas (1139)
FF Gao, R Bhargava, H Yang, Z Li, C Zhao - University of Pittsburgh Medical Center, Pittsburgh, PA; Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 		Add
141 Pelvic High Grade Serous Carcinoma and Association with Serous Tubal Intraepithelial Carcinoma (1272)
H Yang, R Bhargava, X Chen, F Gao, Z Li, C Zhao - Department of Pathology Magee-Womens Hospital of UPMC, Pittsburgh, PA; Conemaugh Memorial Hospital, Johnstown, PA 		Add
142 Site of Origin and High-Grade Pelvic Serous Carcinoma (1188)
DI Lin, EY Chen, MR Nucci, CP Crum - Brigham and Women´s Hospital, Boston, MA 		Add
143 Ovarian Atypical Endometriosis: A Precancerous Lesion (1137)
M Fukunaga - Jikei University Daisan Hospital, Tokyo, Japan 		Add
144 Evidence Supporting Endometriosis as a Precursor of Ovarian Clear Cell and Endometrioid Carcinoma Based on Expression of ARID1A (1089)
A Ayhan, T-L Mao, C-H Wu, H Ogawa, M Futagami, H Mizukami, Y Yokoyama, RJ Kurman, I-M Shih - Johns Hopkins Medical Institutions, Baltimore, MD; Seirei Mikatahara Hospital, Hamamatsu, Japan; National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan; Hirosaki University Graduate School of Medicine, Hirosaki, Japan 		Add
145 Prognostic Impact of an Adenofibromatous Component in Stage I Ovarian Clear Cell Adenocarcinoma (1218)
K Nishikimi, T Kiyokawa, S Tate, M Shozu - Chiba University School of Medicine, Chiba, Japan 		Add
146 HNF-1b in Ovarian Carcinomas with Serous and Clear Cell Changes (1249)
RA Soslow, G Han, CB Gilks, D DeLair - Memorial Sloan-Kettering Cancer Center, New York, NY; Vancouver General Hospital, Vancouver, Canada; University of Calgary, Calgary, Canada 		Add
147 The Lung-Restricted Marker Napsin A Is Highly Expressed in Clear Cell Carcinomas of the Ovary (1170)
PL Kandalaft, C Isacson, AM Gown - PhenoPath Laboratories, PLLC, Seattle, WA; CellNetix Pathology and Laboratories, Seattle, WA; IMPRIS, Seattle, WA 		Add
148 BAF250a (ARID1A) Combined with HNF-1b, ER and P53 Can Distinguish between Ovarian Clear Cell Carcinoma and Papillary Serous Carcinoma (1267)
W Xiao, A Awadallah, W Xin - University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 		Add
149 PARP-Inhibitor Olaparib in the Treatment of Ovarian Clear Cell Cancer: Predictors of Sensitivity and Resistance (1113)
KJ Dedes, P Wilkerson, D Wetterskog, MB Lambros, R Natrajan, DS Tan, A Campion-Flora, DN Rodrigues, A Gauthier, F Daley, CJ Lord, SB Kaye, A Ashworth, JS Reis- Filho - The Institute of Cancer Research, London, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom; Institut Curie, Paris, France 		Add
150 mTOR and HIF-1 Pathway Inhibitors: Exploring the Potential in Clear Cell Carcinoma Variant of Ovary and Endometrium, Comparing with That of Kidney (1164)
H Jaratli, T Jazaerly, K Hayek, S Bandyopadhyay, T Giorgadze, R Ali-Fehmi - Wayne State University, Detroit, MI 		Add
151 Array CGH Analysis Reveals Amplification of Met and AKT2 in Clear Cell Carcinoma of the Ovary (1269)
Y Yamashita, S Akatsuka, Y Yatabe, S Toyokuni - Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Aichi Cancer Center, Nagoya, Aichi, Japan 		Add
152 How Often Does Positive Peritoneal Wash Cytology Independently Upstage and Impact Clinical Management of Ovarian Malignancies? (1274)
J Yu, R Bhargava, RM Austin - Magee-Womens Hospital of UPMC, Pittsburgh, PA 		Add